A phase II clinical trial of four cycles of doxorubicin and cyclophosphamide followed by weekly paclitaxel given concurrently with pazopanib as neoadjuvant therapy followed by postoperative pazopanib for women with locally advanced breast cancer (LABC): A phase II trial of the NSABP Foundation Research Group (FB-6/VEG110264).

P. Rastogi; M. E. Buyse; A. R. Tan; S. A. Jacobs; S. M. Swain; C. E. Geyer; N. Wolmark

doi:10.1200/jco.2010.28.15_suppl.tps107

A phase II clinical trial of four cycles of doxorubicin and cyclophosphamide followed by weekly paclitaxel given concurrently with pazopanib as neoadjuvant therapy followed by postoperative pazopanib for women with locally advanced breast cancer (LABC): A phase II trial of the NSABP Foundation Research Group (FB-6/VEG110264).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps107 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS107-TPS107 ◽

Cited By ~ 1

Author(s):

P. Rastogi ◽

M. E. Buyse ◽

A. R. Tan ◽

S. A. Jacobs ◽

S. M. Swain ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Advanced Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Phase Ii Clinical Trial

Download Full-text

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.1016/j.clbc.2011.04.001 ◽

2011 ◽

Vol 11 (4) ◽

pp. 228-234 ◽

Cited By ~ 14

Author(s):

Priya Rastogi ◽

Marc E. Buyse ◽

Sandra M. Swain ◽

Samuel A. Jacobs ◽

André Robidoux ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Sequential Regimen

Download Full-text

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.029 ◽

2008 ◽

Vol 8 (3) ◽

pp. 257-263 ◽

Cited By ~ 6

Author(s):

John T. Hamm ◽

John W. Wilson ◽

Priya Rastogi ◽

Barry C. Lembersky ◽

George C. Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast

Download Full-text

Abstract P1-11-08: A Multicenter Prospective Phase II Trial of Neo-Adjuvant (FEC 100)/Cisplatin-Docetaxel with or without Trastuzumab in Locally Advanced Breast Cancer. Gulf Oncology Research Group (G0RG-001)

10.1158/0008-5472.sabcs10-p1-11-08 ◽

2010 ◽

Author(s):

TA AL-Tweigeri ◽

AA Alsayed ◽

MM Ibrahim ◽

WM Ashaur ◽

HN Jaafar ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Oncology Research ◽

Prospective Phase

Download Full-text

Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5

Clinical Breast Cancer ◽

10.1016/j.clbc.2016.07.008 ◽

2017 ◽

Vol 17 (1) ◽

pp. 48-54.e3 ◽

Cited By ~ 5

Author(s):

John W. Smith ◽

Marc E. Buyse ◽

Priya Rastogi ◽

Charles E. Geyer ◽

Samuel A. Jacobs ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Advanced Breast Cancer ◽

Neoadjuvant Therapy ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Her2 Positive ◽

Stage Iii Breast Cancer

Download Full-text

Neoadjuvant capecitabine chemoradiation (X-RT) for patients (pts) with locally advanced breast cancer (LABC) failing anthracycline-based neoadjuvant therapy: findings from a prospective phase II trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80375-7 ◽

2006 ◽

Vol 4 (2) ◽

pp. 151 ◽

Cited By ~ 1

Author(s):

M.D.F. Gaui ◽

Amorim ◽

R. Arcuri ◽

G. Pereira ◽

D. Moreira ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Prospective Phase

Download Full-text

OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial.

10.1158/0008-5472.sabcs11-ot2-01-03 ◽

2011 ◽

Author(s):

DA Yardley ◽

NW Peacock ◽

JD Hainsworth ◽

III HA Burris

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Pathologic Complete Response ◽

Complete Response ◽

Advanced Breast

Download Full-text

Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.789 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 789-789

Author(s):

S. Karmarkar ◽

D. Jones ◽

S. Hatch ◽

F. Klementich ◽

K. Ansari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast

Download Full-text

A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80207-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S69-S70

Author(s):

G Fried

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast

Download Full-text

Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.789 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 789-789

Author(s):

S. Karmarkar ◽

D. Jones ◽

S. Hatch ◽

F. Klementich ◽

K. Ansari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast

Download Full-text

Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.876 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 876-876 ◽

Cited By ~ 1

Author(s):

S. X. Franco ◽

A. Perez ◽

C. Frankel ◽

E. Tan-Chiu ◽

L. Schwartzberg ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Preliminary Results ◽

Multicenter Phase

Download Full-text